businesspress24.com - Drugs: Pressemitteilungen - Kategorie - Seite 17
 

Drugs

Category / Pharmaceuticals & Biotech / Drugs


ONL Therapeutics Announces Formation of Scientific Advisory Board

ANN ARBOR, MI: Renowned Retinal Disease Thought Leaders to Help Guide Development of Novel Vision Protection Technology in Age-Related Macular Degeneration (AMD) and Retinal Detachment ...

Aphria Reports Preliminary Q1-2016 Highlights

LEAMINGTON, ONTARIO: Quarterly revenue increase of 90% with registered patients more than doubling ...

Titan Pharmaceuticals Announces FDA''s Acceptance of Resubmission of New Drug Application for Probuphine

SOUTH SAN FRANCISCO, CA: Agency Action Expected by Feb. 27, 2016 on Probuphine for Maintenance Treatment of Opioid Dependence ...

Insys Therapeutics In-Licenses Cannabinoid Inhalation Technology

PHOENIX, AZ: Partnership Enhances the Position of Insys as Potential Leader in Synthetic Pharmaceutical Cannabinoids ...

Vanc Pharmaceuticals Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: - Shipping of pharmacy orders commenced in late Q2-2015 - Roll-out into additional Canadian jurisdictions to commence in Q4-2015 - Additional generic and OTC products being reviewed for portfolio ...

Serenus Biotherapeutics Partners With Xenex to Bring Xenex Disinfection Robots to Africa

DUBLIN, IRELAND and JOHANNESBURG, SOUTH AFRICA: Pulsed Xenon Robotic Antibiotic(TM) Quickly Destroys Deadly Pathogens That Cause Hospital-Acquired Infections ...

Nutra Pharma to Present at Upcoming Investment Conference

CORAL SPRINGS, FL: Nutra Pharma Is Announcing That They Will Present at the Upcoming See Thru Equities Conference in New York City on Thursday, September 10, 2015 ...


Page 17 von 64:  « ..  16 17 18  19  20  21  22  23  24  25  .. » 64





 

Who is online

All members: 10 562
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 78


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.